MedTech Spectrum

Article Name Clinical Trials and Research

Genentech Advances Gazyva® for Lupus with FDA Acceptance of New Application

Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis

21st April, 2026

Nexalin Technology Advances FDA Strategy for Alzheimer’s Treatment

The FDA provided clinical guidance on the proposed Alzheimer’s symptom reduction FDA clinical trial and regulatory pathway

21st April, 2026

Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging

Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows

20th April, 2026

CStone Reveal Preclinical Data on Next-Generation ADCs Targeting EGFR/HER3 and Tumor Heterogeneity

CStone presents preclinical data on three differentiated antibody-drug conjugates, including a dual-target EGFR/HER3 candidate

20th April, 2026

Waters Secures CE Mark for Next-Gen BD BACTEC FXI Blood Culture System

First-of-its-kind blood volume measurement objectively confirms sample collection quality in every bottle processed, improving confidence in blood culture results

20th April, 2026

New Alpha Radiopharmaceutical Imaging Platform Aims to Improve In Vivo Therapy Visualisation

α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies

16th April, 2026

Cepheid And Oxford Nanopore Expand Partnership To Advance Rapid Genomic Workflow For Sepsis Research

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research

15th April, 2026

OSE Immunotherapeutics to Present First-in-Class FPR2 Agonist Antibody Data at AAI 2026

Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy

15th April, 2026

Reflow Medical Reports Positive 12-Month Results from DEEPER REVEAL Trial

The Spur Stent System was granted FDA De Novo clearance in a high-risk, long-lesion population

15th April, 2026

SSRP Institute Adds Medivive to Trusted Partner Network

Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors

15th April, 2026

Seal Shield Launches Complete UV-C Sanitisation Suite Featuring Vioguard

Seal Shield's complete UV-C solution suite is designed to address the full spectrum of device sanitisation needs in clinical environments

14th April, 2026

Virica Biotech and FUJIFILM Biosciences Collaborate to Advance AAV Production Enhancers

Virica and FUJIFILM Biosciences will co-develop an off-the-shelf enhancer–media solution to boost AAV yields and process robustness in FUJIFILM Biosciences BalanCD HEK293 system

09th April, 2026

Enhancing Outcomes in Non-Melanoma Skin Cancer with Next-Gen IGSRT

The conversation explores how this innovation is shaping the future of dermatologic oncology, where real-time imaging, AI-driven insights, and patient-centric care models converge to deliver more effective and accessible cancer treatment

07th April, 2026

CellCarta and Pillar Biosciences Partner to Accelerate Oncology NGS Testing

This partnership is designed to remove that bottleneck by combining Pillar's portfolio of oncoReveal NGS-based kitted panels with CellCarta's global clinical trial testing execution

06th April, 2026

MedOne, Nanodropper Improve Eye Drop Adherence with MediSplit Initiative

The MediSplit program provides eligible MedOne members with complimentary Nanodroppers when filling select ophthalmic prescriptions

06th April, 2026

NAVER D2SF Backs Soundable Health in Follow-On Round to Scale Acoustic AI Diagnostics

Soundable Health has developed proprietary AI models that analyse acoustic signals generated by the human body to monitor health conditions

31st March, 2026

New Trial Data Supports EKOS System for Acute Pulmonary Embolism Treatment

A global randomised trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone

30th March, 2026